Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history
- PMID: 24685909
- PMCID: PMC4262726
- DOI: 10.1136/annrheumdis-2013-205009
Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history
Erratum in
- Ann Rheum Dis. 2015 Aug;74(8):1528
Abstract
Objective: To develop and validate rheumatoid arthritis (RA) risk models based on family history, epidemiologic factors and known genetic risk factors.
Methods: We developed and validated models for RA based on known RA risk factors, among women in two cohorts: the Nurses' Health Study (NHS, 381 RA cases and 410 controls) and the Epidemiological Investigation of RA (EIRA, 1244 RA cases and 971 controls). Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC) in logistic regression models for the study population and for those with positive family history. The joint effect of family history with genetics, smoking and body mass index (BMI) was evaluated using logistic regression models to estimate ORs for RA.
Results: The complete model including family history, epidemiologic risk factors and genetics demonstrated AUCs of 0.74 for seropositive RA in NHS and 0.77 for anti-citrullinated protein antibody (ACPA)-positive RA in EIRA. Among women with positive family history, discrimination was excellent for complete models for seropositive RA in NHS (AUC 0.82) and ACPA-positive RA in EIRA (AUC 0.83). Positive family history, high genetic susceptibility, smoking and increased BMI had an OR of 21.73 for ACPA-positive RA.
Conclusions: We developed models for seropositive and seronegative RA phenotypes based on family history, epidemiological and genetic factors. Among those with positive family history, models using epidemiologic and genetic factors were highly discriminatory for seropositive and seronegative RA. Assessing epidemiological and genetic factors among those with positive family history may identify individuals suitable for RA prevention strategies.
Keywords: Epidemiology; Gene Polymorphism; Rheumatoid Arthritis.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
References
-
- Frisell T, Holmqvist M, Kallberg H, Klareskog L, Alfredsson L, Askling J. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum. 2013;65(11):2773–2782. - PubMed
-
- Majka DS, Holers VM. Can we accurately predict the development of rheumatoid arthritis in the preclinical phase? Arthritis Rheum. 2003;48(10):2701–2705. - PubMed
-
- Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81. - PubMed
-
- Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med. 2006;119(6):503 e1–503 e9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AR049880/AR/NIAMS NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- AR047782/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- AR052403/AR/NIAMS NIH HHS/United States
- CA067262/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- CA050385/CA/NCI NIH HHS/United States
- K24 AR066109/AR/NIAMS NIH HHS/United States
- R01 AR059073/AR/NIAMS NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- CA087969/CA/NCI NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
- CA049449/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
